Q2 FY2026 EarningsQ2 FY26 beat consensus across all key metrics: adjusted EPS reached $7.45 vs. $6.21 expected, and operating revenue was $49.8B vs. $48.6B consensus. Performance was driven by higher premium yields in Health Benefits and Carelon's growth, despite membership attrition. Consequently, management raised FY26 adjusted EPS guidance to at least $27.00, well ahead of prior expectations.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Elevance Health(ELV) the Revenue is 49.83 B (+0.82%), Beat estimate;the EBIT is 2.522 B (-15.2%), Beat estimate;the EPS is 6.71 (-13.08%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
49.83B0.82%
48.63B1.61%
+1.20B2.43%
EBITExceed expectations
2.52B15.20%
2.14B27.88%
+0.38B12.68%
EPSExceed expectations
6.7113.08%
5.750225.52%
+0.959812.44%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf